Cibinqo (Abrocitinib)
Cibinqo (Abrocitinib)
Cibinqo (Abrocitinib) is an oral medication used to treat moderate to severe atopic dermatitis (eczema) in adults who have not responded well to other treatments. It is a selective Janus kinase (JAK) inhibitor, working by targeting and reducing inflammation at its source, providing relief from itching, rashes, and other eczema symptoms.
Why Choose Cibinqo (Abrocitinib)?
- Effective Symptom Relief: Reduces the severity of eczema symptoms such as itching, redness, and inflammation.
- Fast-Acting: Many patients experience symptom relief within days of starting treatment.
- Oral Convenience: As a daily oral pill, Cibinqo offers ease of use compared to topical therapies.
- Comprehensive Approach: Targets the inflammatory pathway directly to address the root cause of eczema.
- Improved Skin Quality: Helps improve skin clarity and overall appearance, restoring comfort and confidence.
How to Use Cibinqo (Abrocitinib)?
- Take as Prescribed: Take one tablet daily with or without food, as directed by your healthcare provider.
- Consistent Timing: Try to take Cibinqo at the same time each day to maintain consistent levels in your body.
- Do Not Double Dose: If you miss a dose, skip it and take the next dose at the scheduled time.
- Consult Before Changes: Always consult your healthcare provider before making any changes to your dose or discontinuing the medication.
- Regular Check-Ins: Schedule follow-ups with your doctor to monitor your progress and adjust the treatment if needed.
Important Safety Information about Cibinqo
- Infection Risk: Cibinqo may increase the risk of serious infections; avoid contact with people who have active infections.
- Blood Clots and Heart Concerns: Some people taking JAK inhibitors have had blood clots, heart attacks, and other cardiovascular issues; discuss your health history with your doctor.
- Avoid Live Vaccines: Do not receive live vaccines during Cibinqo treatment without medical approval.
- Liver Function: Cibinqo may affect liver enzymes; regular blood tests are recommended to monitor liver health.
Fact Table
Facts | Details |
Generic Name | Abrocitinib |
Brand Name | Cibinqo |
Drug Class | Janus Kinase (JAK) Inhibitor |
Form | Oral Tablet |
Strengths Available | 50 mg, 100 mg, and 200 mg tablets |
Indication | Moderate to severe atopic dermatitis (eczema) in adults |
Dosage | Once daily, as prescribed by a healthcare provider |
How It Works | Reduces inflammation by inhibiting Janus kinase (JAK) enzymes involved in the immune response |
Administration | Can be taken with or without food |
Common Side Effects | Nausea, headache, increased cholesterol, dizziness, and fatigue |
Special Precautions | Avoid live vaccines; regular blood tests are recommended to monitor liver function, cholesterol, and overall health |
Use in Pregnancy | Safety in pregnancy not established; consult with healthcare provider |
Storage Instructions | Store at room temperature, away from moisture and light |
FDA Approval Year | 2022 |
Key Benefits | Reduces itching and inflammation, convenient daily dosing, rapid symptom relief in some patients, and potential improvement in skin appearance |
Monitoring Requirements | Regular follow-up visits and blood tests are recommended to monitor liver function, lipid levels, and overall health |
Common Side Effects
Like all medications, Cibinqo (Abrocitinib) can cause side effects, although not everybody gets them. Understanding these side effects can help you use this medication safely and effectively.
- Nausea
- Headaches
- Increased Cholesterol
- Dizziness
- Fatigue
If you experience any side effects, discuss them with your healthcare provider. They can offer advice and may adjust your treatment if necessary. Report any severe or unexpected side effects immediately.
How Can You Buy Cibinqo (Abrocitinib)?
You can order Cibinqo (Abrocitinib) using these methods on our website:
- Order Online
- Order by Phone
- Order by Fax
- Order your refills
Visit our How to order page.